The ubiquitous choline transporter SLC44A1

Central Nervous System Agents in Medicinal Chemistry

Volumn 12, Issue 2, 2012, Pages 70-81

  Michel, Vera ^a   Bakovic, Marica ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Choline transport; Choline transporter like protein; Hemicholinium; SLC44A1

Indexed keywords

ACETYLCHOLINE; CARRIER PROTEINS AND BINDING PROTEINS; CHOLINE; CHOLINE TRANSPORTER LIKE PROTEIN 1; PHOSPHOLIPID; UNCLASSIFIED DRUG;

BINDING AFFINITY; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; GENE OVEREXPRESSION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW;

EID: 84862553171     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/187152412800792733     Document Type: Review

References (105)

1. Zeisel, S.H., Choline deficiency. J. Nutr. Biochem., 1990, 1, (7), 332-349.
2. Tucek, S., Regulation of acetylcholine synthesis in the brain. J. Neurochem., 1985, 44, (1), 11-24.
3. Jacob, R. A.; Jenden, D. J.; Allman-Farinelli, M. A.; Swendseid, M. E., Folate nutriture alters choline status of women and men fed low choline diets. J. Nutr., 1999, 129, (3), 712-717.
4. Zeisel, S., In Modern Nutrition in Health and Disease, 1994; pp 449-458.
5. Blusztajn, J. K.; Wurtman, R. J. Choline and cholinergic neurons. Science, 1983, 221, (4611), 614-620.
6. Spector, R. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. Neurochem., 1989, 53, (6), 1667-1674.
7. Hensley, K.; Kotake, Y.; Sang, H.; Pye, Q. N.; Wallis, G. L.; Kolker, L. M.; Tabatabaie, T.; Stewart, C. A.; Konishi, Y.; Nakae, D.; Floyd, R. A. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis, 2000, 21, (5), 983-989.
8. Meck, W. H.; Smith, R. A.; Williams, C. L., Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory. Dev. Psychobiol., 1988, 21, (4), 339-353.
9. Wurtman, R. J., Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci., 1992, 15, (4), 117-122.
10. Zeisel, S., H. Choline. A nutrient that is involved in the regulation of cell proliferation, cell death, and cell transformation. Adv. Exp. Med. Biol., 1996, 399, 131-141.
11. Ghoshal, A. K. New insight into the biochemical pathology of liver in choline deficiency. Crit. Rev. Biochem. Mol. Biol., 1995, 30, (4), 263-273.
12. Park, E. I.; Garrow, T. A., Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J. Biol. Chem., 1999, 274, (12), 7816-7824.
13. Walkey, C. J.; Yu, L.; Agellon, L. B.; Vance, D. E., Biochemical and evolutionary significance of phospholipid methylation. J. Biol. Chem., 1998, 273, (42), 27043-27046.
14. Garner, S. C.; Chou, S. C.; Mar, M. H.; Coleman, R. A.; Zeisel, S. H., Characterization of choline metabolism and secretion by human placental trophoblasts in culture. Biochim. Biophys. Acta, 1993, 1168, (3), 358-364.
15. Ullrich, K. J. Specificity of transporters for 'organic anions' and 'organic cations' in the kidney. Biochim. Biophys. Acta, 1994, 1197, (1), 45-62.
16. Lee RD K. Y., Morris ME, Hepatic transport of choline in basolateral liver plasma membrane vesicles. FASEB J., 1992, 8, A1485
17. Fisher, A. B.; Chander, A.; Dodia, C.; Reicherter, J.; Kleinzeller, A. Choline transport by lung epithelium. Am. J. Respir. Cell Mol. Biol., 1989, 1, (6), 455-462.
18. Deves, R.; Krupka, R. M. The binding and translocation steps in transport as related to substrate structure. A study of the choline carrier of erythrocytes. Biochim. Biophys. Acta, 1979, 557, (2), 469-485.
19. Sawada, N.; Takanaga, H.; Matsuo, H.; Naito, M.; Tsuruo, T.; Sawada, Y. Choline uptake by mouse brain capillary endothelial cells in culture. J. Pharm. Pharmacol., 1999, 51, (7), 847-852.
20. van Rossum, G. D.; Boyd, C. A. Sodium-dependent and -independent choline uptake by type II epithelial cells from rat lung. J. Membr. Biol., 1998, 162, (2), 147-156.
21. Haga, T., Synthesis and release of (14 C)acetylcholine in synaptosomes. J. Neurochem., 1971, 18, (6), 781-798.
22. Grassl, S. M., Choline transport in human placental brush-border membrane vesicles. Biochim. Biophys. Acta, 1994, 1194, (1), 203-213.
23. Takano, M.; Katsura, T.; Tomita, Y.; Yasuhara, M.; Hori, R., Transport mechanism of choline in rat renal brush-border membrane. Biol. Pharm. Bull., 1993, 16, (9), 889-894.
24. Dantzler, W. H.; Evans, K. K.; Wright, S. H. Basolateral choline transport in isolated rabbit renal proximal tubules. Pflugers. Arch. 1998, 436, (6), 899-905.
25. Koepsell, H.; Gorboulev, V.; Arndt, P. Molecular pharmacology of organic cation transporters in kidney. J. Membr. Biol., 1999, 167, (2), 103-117.
26. Schloss, P.; Mayser, W.; Betz, H. The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues. Biochem. Biophys. Res. Commun., 1994, 198, (2), 637-645.
27. Okuda, T.; Haga, T.; Kanai, Y.; Endou, H.; Ishihara, T.; Katsura, I. Identification and characterization of the high-affinity choline transporter. Nat. Neurosci., 2000, 3, (2), 120-125.
28. O'Regan, S.; Traiffort, E.; Ruat, M.; Cha, N.; Compaore, D.; Meunier, F. M., An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, (4), 1835-1840.
29. Slotkin, T. A.; Nemeroff, C. B.; Bissette, G.; Seidler, F. J., Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J. Clin. Invest., 1994, 94, (2), 696-702.
30. Scott, J. M. Homocysteine and cardiovascular risk. Am. J. Clin. Nutr., 2000, 72, (2), 333-334.
31. Zhou, M.; Engel, A. G.; Auerbach, A. Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, (18), 10466-10471.
32. Blumenfeld, A.; Slaugenhaupt, S. A.; Liebert, C. B.; Temper, V.; Maayan, C.; Gill, S.; Lucente, D. E.; Idelson, M.; MacCormack, K.; Monahan, M. A.; Mull, J.; Leyne, M.; Mendillo, M.; Schiripo, T.; Mishori, E.; Breakefield, X.; Axelrod, F. B.; Gusella, J. F. Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31. Am. J. Hum. Genet., 1999, 64, (4), 1110-1118.
33. Apparsundaram, S.; Ferguson, S. M.; Blakely, R. D. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem. Soc. Trans., 2001, 29, (Pt 6), 711-716.
34. Fullerton, M. D.; Wagner, L.; Yuan, Z.; Bakovic, M. Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocytederived macrophages. Am. J. Physiol. Cell Physiol., 2006, 290, (4), C1230-C1238.
35. Inazu, M.; Takeda, H.; Matsumiya, T. Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. J. Neurochem., 2005, 94, (5), 1427-137.
36. Fujita, T.; Shimada, A.; Okada, N.; Yamamoto, A. Functional characterization of Na+-independent choline transport in primary cultures of neurons from mouse cerebral cortex. Neurosci., 2006, 393, (2-3), 216-221.
37. Riley, S. P.; Talbot, N. J.; Ahmed, M. J.; Jouhal, K.; Hendry, B. M., Characterization of human erythrocyte choline transport in chronic renal failure. Nephrol. Dial. Transplant., 1997, 12, (9), 1921-1927.
38. Iorio, E.; Mezzanzanica, D.; Alberti, P.; Spadaro, F.; Ramoni, C.; D'Ascenzo, S.; Millimaggi, D.; Pavan, A.; Dolo, V.; Canevari, S.; Podo, F., Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res., 2005, 65, (20), 9369-9376.
39. Villa, A. M.; Caporizzo, E.; Papagni, A.; Miozzo, L.; Del Buttero, P.; Grilli, M. D.; Amboldi, N.; Fazio, F.; Doglia, S. M.; Giglioni, B., Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy. Eur. J. Cancer, 2005, 41, (10), 1453-1459.
40. Fisher, A. B.; Dodia, C.; Chander, A.; Kleinzeller, A., Transport of choline by plasma membrane vesicles from lung-derived epithelial cells. Am. J. Physiol., 1992, 263, (6 Pt 1), C1250-C1257.
41. Simon, J. R.; Atweh, S.; Kuhar, M. J. Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J. Neurochem., 1976, 26, (5), 909-922.
42. Porter, R. K.; Scott, J. M.; Brand, M. D., Choline transport into rat liver mitochondria. Characterization and kinetics of a specific transporter. J. Biol. Chem., 1992, 267, (21), 14637-14646.
43. Okuda, T.; Haga, T., Functional characterization of the human high-affinity choline transporter. FEBS Lett., 2000, 484, (2), 92-97.
44. Okuda, T.; Haga, T. High-affinity choline transporter. Neurochem. Res., 2003, 28, (3-4), 483-488.
45. Traiffort, E.; Ruat, M.; O'Regan, S.; Meunier, F. M. Molecular characterization of the family of choline transporter-like proteins and their splice variants. J. Neurochem., 2005, 92, (5), 1116-1125.
46. Nakamura, T.; Fujiwara, R.; Ishiguro, N.; Oyabu, M.; Nakanishi, T.; Shirasaka, Y.; Maeda, T.; Tamai, I. Involvement of choline transporter-like proteins, CTL1 and CTL2, in glucocorticoidinduced acceleration of phosphatidylcholine synthesis via increased choline uptake. Biol. Pharm. Bull., 2010, 33, (4), 691-696.
47. Wille, S.; Szekeres, A.; Majdic, O.; Prager, E.; Staffler, G.; Stockl, J.; Kunthalert, D.; Prieschl, E. E.; Baumruker, T.; Burtscher, H.; Zlabinger, G. J.; Knapp, W.; Stockinger, H. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J. Immunol., 2001, 167, (10), 5795-5804.
48. Yuan, Z.; Wagner, L.; Poloumienko, A.; Bakovic, M. Identification and expression of a mouse muscle-specific CTL1 gene. Gene, 2004, 341, 305-312.
49. Yuan, Z.; Tie, A.; Tarnopolsky, M.; Bakovic, M. Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1. Physiol. Genom., 2006, 26, (1), 76-90.
50. Meunier, F. M.; O'Regan, S. Expression of CTL1 in myelinating structures of Torpedo marmorata. Neuroreport, 2002, 13, (13), 1617-1620.
51. Michel, V.; Yuan, Z.; Ramsubir, S.; Bakovic, M. Choline transport for phospholipid synthesis. Exp, Biol. Med. (Maywood) 2006, 231, (5), 490-504.
52. Michel, V.; Bakovic, M., The solute carrier 44A1 is a mitochondrial protein and mediates choline transport. FASEB J, 2009.
53. Jones, D. T. Improving the accuracy of transmembrane protein topology prediction using evolutionary information. Bioinformatics, 2007, 23, (5), 538-544.
54. Johns, S. J TOPO2 Transmembrane protein display software.
55. Blom, N.; Gammeltoft, S.; Brunak, S. Sequence and structurebased prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol., 1999, 294, (5), 1351-1362.
56. Gupta, R., Jung, E., and S. Brunak, Prediction of N-glycosylation sites in human proteins. in preparation 2004.
57. Rost, B.; Yachdav, G.; Liu, J. The PredictProtein server. Nucleic Acids Res., 2004, 32, (Web Server issue), W321-W326.
58. O'Regan, S.; Meunier, F. M. Selection and characterization of the choline transport mutation suppressor from Torpedo electric lobe, CTL1. Neurochem. Res., 2003, 28, (3-4), 551-555.
59. Zufferey, R.; Santiago, T. C.; Brachet, V.; Ben Mamoun, C. Reexamining the role of choline transporter-like (Ctlp) proteins in choline transport. Neurochem. Res., 2004, 29, (2), 461-467.
60. Tomi, M.; Arai, K.; Tachikawa, M.; Hosoya, K. Na(+)-independent choline transport in rat retinal capillary endothelial cells. Neurochem. Res., 2007, 32, (11), 1833-1842.
61. Kekuda, R.; Prasad, P. D.; Wu, X.; Wang, H.; Fei, Y. J.; Leibach, F. H.; Ganapathy, V. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J. Biol. Chem., 1998, 273, (26), 15971-15979.
62. Wu, X.; Huang, W.; Ganapathy, M. E.; Wang, H.; Kekuda, R.; Conway, S. J.; Leibach, F. H.; Ganapathy, V., Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am. J. Physiol. Renal. Physiol., 2000, 279, (3), F449-F458.
63. Kaplan, C. P.; Porter, R. K.; Brand, M. D. The choline transporter is the major site of control of choline oxidation in isolated rat liver mitochondria. FEBS Lett., 1993, 321, (1), 24-26.
64. O'Donoghue, N.; Sweeney, T.; Donagh, R.; Clarke, K. J.; Porter, R. K. Control of choline oxidation in rat kidney mitochondria. Biochim. Biophys. Acta, 2009, 1787, (9), 1135-1139.
65. Porter, R. K.; Scott, J. M.; Brand, M. D. Characterization of betaine efflux from rat liver mitochondria. Biochim. Biophys. Acta, 1993, 1141, (2-3), 269-274.
66. McMurray, W. C. Origins of the phospholipids in animal mitochondria. Biochem. Cell Biol., 1986, 64, (11), 1115-1124.
67. Voelker, D. R., Lipid synthesis and transport in mitochondrial biogenesis. In Topics in Current Genetics, Springer Berlin/Heidelberg, 2004; Vol. Volume 8/2004.
68. Jin, J.K.; Kim, N.H.; Lee, Y.J.; Kim, Y. S.; Choi, E. K.; Kozlowski, P.B.; Park, M. H.; Kim, H. S.; Min do, S. Phospholipase D1 is up regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients. Neurosci. Lett., 2006, 407, (3), 263-267.
69. Madesh, M.; Balasubramanian, K. A. Cyclosporin A inhibits oxidant and calcium stimulated phospholipase D activity in the rat intestinal mitochondria. Biochim. Biophys. Acta, 1998, 1389, (3), 206-212.
70. Birbes, H.; El Bawab, S.; Hannun, Y. A.; Obeid, L. M. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J., 2001, 15, (14), 2669-2679.
71. Stone, S. J.; Vance, J. E. Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J. Biol. Chem., 2000, 275, (44), 34534-34540.
72. Michel, V.; Singh, R. K.; Bakovic, M., The impact of choline availability on muscle lipid metabolism. Food Funct., 2 (1), 53-62.
73. Yabuki, M.; Inazu, M.; Yamada, T.; Tajima, H.; Matsumiya, T., Molecular and functional characterization of choline transporter in rat renal tubule epithelial NRK-52E cells. Arch. Biochem. Biophys., 2009, 485, (1), 88-96.
74. Dohda, T.; Maljukova, A.; Liu, L.; Heyman, M.; Grander, D.; Brodin, D.; Sangfelt, O.; Lendahl, U. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp. Cell Res., 2007, 313, (14), 3141-3152.
75. Moestue, S. A.; Borgan, E.; Huuse, E. M.; Lindholm, E. M.; Sitter, B.; Borresen-Dale, A. L.; Engebraaten, O.; Maelandsmo, G. M.; Gribbestad, I. S. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer, 2010, 10, 433.
76. Ding, L.; Ellis, M. J.; Li, S.; Larson, D. E.; Chen, K.; Wallis, J. W.; Harris, C. C.; McLellan, M. D.; Fulton, R. S.; Fulton, L. L.; Abbott, R. M.; Hoog, J.; Dooling, D. J.; Koboldt, D. C.; Schmidt, H.; Kalicki, J.; Zhang, Q.; Chen, L.; Lin, L.; Wendl, M. C.; McMichael, J. F.; Magrini, V. J.; Cook, L.; McGrath, S. D.; Vickery, T. L.; Appelbaum, E.; Deschryver, K.; Davies, S.; Guintoli, T.; Lin, L.; Crowder, R.; Tao, Y.; Snider, J. E.; Smith, S. M.; Dukes, A. F.; Sanderson, G. E.; Pohl, C. S.; Delehaunty, K. D.; Fronick, C. C.; Pape, K. A.; Reed, J. S.; Robinson, J. S.; Hodges, J. S.; Schierding, W.; Dees, N. D.; Shen, D.; Locke, D. P.; Wiechert, M. E.; Eldred, J. M.; Peck, J. B.; Oberkfell, B. J.; Lolofie, J. T.; Du, F.; Hawkins, A. E.; O'Laughlin, M. D.; Bernard, K. E.; Cunningham, M.; Elliott, G.; Mason, M. D.; Thompson, D. M., Jr.; Ivanovich, J. L.; Goodfellow, P. J.; Perou, C. M.; Weinstock, G. M.; Aft, R.; Watson, M.; Ley, T. J.; Wilson, R. K.; Mardis, E. R. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature, 2010, 464, (7291), 999-1005.
77. Nakagawa, T.; Kollmeyer, T. M.; Morlan, B. W.; Anderson, S. K.; Bergstralh, E. J.; Davis, B. J.; Asmann, Y. W.; Klee, G. G.; Ballman, K. V.; Jenkins, R. B. A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One, 2008, 3, (5), e2318.
78. McCabe, C. D.; Spyropoulos, D. D.; Martin, D.; Moreno, C. S. Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. Cancer Res., 2008, 68, (6), 1988-1996.
79. Stipp, C. S., Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev. Mol. Med., 2010, 12, e3.
80. Mathivanan, S.; Lim, J. W.; Tauro, B. J.; Ji, H.; Moritz, R. L.; Simpson, R. J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell Proteom., 2010, 9, (2), 197-208.
81. Brandes, A. H.; Ward, C. S.; Ronen, S. M. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2. Breast Cancer Res., 2010, 12, (5), R84.
82. Dejeans, N.; Maier, J. A.; Tauveron, I.; Milenkovic, D.; Mazur, A. Modulation of gene expression in endothelial cells by hyperlipaemic postprandial serum from healthy volunteers. Genes Nutr., 2010, 5, (3), 263-274.
83. Dieterich, C.; Puey, A.; Lin, S.; Swezey, R.; Furimsky, A.; Fairchild, D.; Mirsalis, J. C.; Ng, H. H. Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol. Sci., 2009, 107, (1), 258-269.
84. Machova, E.; O'Regan, S.; Newcombe, J.; Meunier, F. M.; Prentice, J.; Dove, R.; Lisa, V.; Dolezal, V. Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake. J. Neurochem., 2009, 110, (4), 1297-1309.
85. Lee, N. Y.; Choi, H. M.; Kang, Y. S. Choline transport via choline transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT. Placenta, 2009, 30, (4), 368-374.
86. Yamada, T.; Inazu, M.; Tajima, H.; Matsumiya, T. Functional expression of choline transporter-like protein 1 (CTL1) in human neuroblastoma cells and its link to acetylcholine synthesis. Neurochem. Int., 2011, 58, (3), 354-365.
87. Davidson, M. E.; Kerepesi, L. A.; Soto, A.; Chan, V. T. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats. Arch. Toxicol., 2009, 83, (8), 747-762.
88. Becanovic, K.; Pouladi, M. A.; Lim, R. S.; Kuhn, A.; Pavlidis, P.; Luthi-Carter, R.; Hayden, M. R.; Leavitt, B. R. Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum. Mol. Genet., 2010, 19, (8), 1438-1452.
89. Cui, L.; Jeong, H.; Borovecki, F.; Parkhurst, C. N.; Tanese, N.; Krainc, D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 2006, 127, (1), 59-69.
90. Arlotta, P.; Molyneaux, B. J.; Jabaudon, D.; Yoshida, Y.; Macklis, J. D. Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J. Neurosci., 2008, 28, (3), 622-632.
91. Hodges, A.; Hughes, G.; Brooks, S.; Elliston, L.; Holmans, P.; Dunnett, S. B.; Jones, L., Brain gene expression correlates with changes in behavior in the R6/1 mouse model of Huntington's disease. Genes Brain Behav., 2008, 7, (3), 288-299.
92. Brouillet, E.; Hantraye, P.; Ferrante, R. J.; Dolan, R.; Leroy-Willig, A.; Kowall, N. W.; Beal, M. F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. U. S. A., 1995, 92, (15), 7105-71059.
93. Turner, C.; Schapira, A. H. Mitochondrial matters of the brain: the role in Huntington's disease. J. Bioenerg. Biomembr, 2010, 42, (3), 193-198.
94. Hartl, D.; Irmler, M.; Romer, I.; Mader, M. T.; Mao, L.; Zabel, C.; de Angelis, M. H.; Beckers, J.; Klose, J. Transcriptome and proteome analysis of early embryonic mouse brain development. Proteomics, 2008, 8, (6), 1257-1265.
95. Nielsen, J. A.; Maric, D.; Lau, P.; Barker, J. L.; Hudson, L. D. Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J. Neurosci., 2006, 26, (39), 9881-9891.
96. Chen-Plotkin, A. S.; Geser, F.; Plotkin, J. B.; Clark, C. M.; Kwong, L. K.; Yuan, W.; Grossman, M.; Van Deerlin, V. M.; Trojanowski, J. Q.; Lee, V. M. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration. Hum. Mol. Genet., 2008, 17, (10), 1349-1362.
97. Ahmed, Z.; Mackenzie, I. R.; Hutton, M. L.; Dickson, D. W. Progranulin in frontotemporal lobar degeneration and neuroinflammation. J. Neuroinflam., 2007, 4, 7.
98. Beglopoulos, V.; Sun, X.; Saura, C. A.; Lemere, C. A.; Kim, R. D.; Shen, J. Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J. Biol. Chem., 2004, 279, (45), 46907-46914.
99. Stein, T. D.; Anders, N. J.; DeCarli, C.; Chan, S. L.; Mattson, M. P.; Johnson, J. A. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J. Neurosci., 2004, 24, (35), 7707-7717.
100. McGrath, M. F.; de Bold, A. J. Transcriptional analysis of the mammalian heart with special reference to its endocrine function. BMC Genom., 2009, 10, 254.
101. Moran, L. B.; Duke, D. C.; Deprez, M.; Dexter, D. T.; Pearce, R. K.; Graeber, M. B. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics, 2006, 7, (1), 1-11.
102. Dunckley, T.; Beach, T. G.; Ramsey, K. E.; Grover, A.; Mastroeni, D.; Walker, D. G.; LaFleur, B. J.; Coon, K. D.; Brown, K. M.; Caselli, R.; Kukull, W.; Higdon, R.; McKeel, D.; Morris, J. C.; Hulette, C.; Schmechel, D.; Reiman, E. M.; Rogers, J.; Stephan, D. A. Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging, 2006, 27, (10), 1359-1371.
103. Koh, S.; Chung, H.; Xia, H.; Mahadevia, A.; Song, Y. Environmental enrichment reverses the impaired exploratory behavior and altered gene expression induced by early-life seizures. J. Child Neurol., 2005, 20, (10), 796-802.
104. Pachiappan, A.; Thwin, M. M.; Manikandan, J.; Gopalakrishnakone, P. Glial inflammation and neurodegeneration induced by candoxin, a novel neurotoxin from Bungarus candidus venom: global gene expression analysis using microarray. Toxicon, 2005, 46, (8), 883-899.
105. Molofsky, A. V.; Pardal, R.; Iwashita, T.; Park, I. K.; Clarke, M. F.; Morrison, S. J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature, 2003, 425, (6961), 962-967.